Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.
- Published In:
- Heart (British Cardiac Society), 110(19), 1165-1171 (2024)
- Authors:
- Krumholz, Harlan M, de Lemos, James A, Sattar, Naveed(10), Linetzky, Bruno, Sharma, Palash, Mast, Casey J, Ahmad, Nadia N, Bunck, Mathijs C, Stefanski, Adam
- Database ID:
- RPEP-08604
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08604APA
Krumholz, Harlan M; de Lemos, James A; Sattar, Naveed; Linetzky, Bruno; Sharma, Palash; Mast, Casey J; Ahmad, Nadia N; Bunck, Mathijs C; Stefanski, Adam. (2024). Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.. Heart (British Cardiac Society), 110(19), 1165-1171. https://doi.org/10.1136/heartjnl-2024-324170
MLA
Krumholz, Harlan M, et al. "Tirzepatide and blood pressure reduction: stratified analyses of the SURMOUNT-1 randomised controlled trial.." Heart (British Cardiac Society), 2024. https://doi.org/10.1136/heartjnl-2024-324170
RethinkPeptides
RethinkPeptides Research Database. "Tirzepatide and blood pressure reduction: stratified analyse..." RPEP-08604. Retrieved from https://rethinkpeptides.com/research/krumholz-2024-tirzepatide-and-blood-pressure
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.